Log In
Print this Print this

Chrysalin, rusalatide acetate (TP508)

  Manage Alerts
Collapse Summary General Information
Company Chrysalis BioTherapeutics Inc.
Description23-amino acid synthetic peptide portion of the receptor-binding domain of human thrombin
Molecular Target Thrombin receptor
Mechanism of ActionThrombin receptor agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationPoisoning
Indication DetailsTreat acute radiation syndrome (ARS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today